Treace Medical Concepts
TMCI
127 hedge funds and large institutions have $563M invested in Treace Medical Concepts in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 47 increasing their positions, 37 reducing their positions, and 28 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
27% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 37
14% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 28
10% more capital invested
Capital invested by funds: $514M → $563M (+$48.8M)
7.87% more ownership
Funds ownership: 63.68% → 71.54% (+7.9%)
3% more funds holding
Funds holding: 123 → 127 (+4)
42% less call options, than puts
Call options by funds: $2.11M | Put options by funds: $3.62M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$60.8M |
| 2 |
AC
Armistice Capital
New York
|
+$28.9M |
| 3 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$17.7M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$12.6M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
+$10.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$42.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$16.4M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$14.8M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$9.03M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$7.48M |
TMCI Hedge Fund Activity: Q4 2023 in Review
127 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q4 2023, worth a combined $563M — up 9.5% from $514M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new TMCI positions and 28 closed out — a net gain of 4 holders — while 47 added to existing stakes and 37 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $60.8M. The largest seller was AllianceBernstein, cutting an estimated $42.9M.
- 127 institutional investors held Treace Medical Concepts (TMCI) as of Q4 2023, up from 123 in Q3 2023.
- Funds reported $563M of Treace Medical Concepts stock for Q4 2023, up 9.5% quarter-over-quarter.
- 32 funds opened new Treace Medical Concepts positions in Q4 2023 and 28 closed out, a net change of +4 holders.
- The largest Treace Medical Concepts buyer in Q4 2023 was Morgan Stanley, an estimated $60.8M added.
- The largest Treace Medical Concepts seller in Q4 2023 was AllianceBernstein, an estimated $42.9M sold.
Based on aggregated 13F filings for Q4 2023.